Host–Guest Interaction Study of Olmesartan Medoxomil with β-Cyclodextrin Derivatives

Olmesartan medoxomil (OLM) is a selective angiotensin II receptor antagonist used in the treatment of hypertension. Its therapeutic potential is limited by its poor water solubility, leading to poor bioavailability. Encapsulation of the drug substance by two methylated cyclodextrins, namely randomly...

書誌詳細
出版年:	Molecules
主要な著者:	Minodora Andor, Claudia Temereancă, Laura Sbârcea, Adriana Ledeți, Dana Emilia Man, Cristian Mornoș, Amalia Ridichie, Denisa Cîrcioban, Gabriela Vlase, Paul Barvinschi, Angela Caunii, Renata-Maria Văruţ, Cristina Maria Trandafirescu, Valentina Buda, Ionuț Ledeți, Matilda Rădulescu
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2024-05-01
主題:	olmesartan medoxomil cyclodextrins inclusion complex molecular encapsulation solubility enhancement spectroscopic methods
オンライン･アクセス:	https://www.mdpi.com/1420-3049/29/10/2209

類似資料

Host–Guest Complexation of Olmesartan Medoxomil by Heptakis(2,6-di-O-methyl)-β-cyclodextrin: Compatibility Study with Excipients
著者:: Dana Emilia Man, 等
出版事項: (2024-12-01)

EVALUATION OF ANTIHYPERTENSIVE THERAPY WITH THE COMBINATION OF OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
著者:: Steven G. Chrysant, 等
出版事項: (2011-06-01)

EFFECT OF ANGIOTENSIN RECEPTOR BLOCKADE ON ENDOTHELIAL FUNCTION: FOCUS ON OLMESARTAN MEDOXOMIL
著者:: C. Ferrario
出版事項: (2010-12-01)

Olmesartan medoxomil-loaded mixed micelles: Preparation, characterization and in-vitro evaluation
著者:: Mohamed A. El-Gendy, 等
出版事項: (2017-12-01)

Interaction and Compatibility Studies in the Development of Olmesartan Medoxomil and Hydrochlorothiazide Formulations under a Real Manufacturing Process
著者:: Mac Arturo Murillo-Fernández, 等
出版事項: (2022-02-01)

Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation
著者:: Rania Moataz El-Dahmy, 等
出版事項: (2023-03-01)

Cleaning validation for residual estimation of olmesartan medoxomil on stainless steel surface of pharmaceutical manufacturing equipments using swab sampling and HPLC-DAD method
著者:: Nitin Dubey, 等
出版事項: (2013-06-01)

Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)
著者:: Park JS, 等
出版事項: (2016-08-01)

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
著者:: R. P. Mason
出版事項: (2012-06-01)

Synthesis and Physicochemical Characterization of the Process-Related Impurities of Olmesartan Medoxomil. Do 5-(Biphenyl-2-yl)-1-triphenylmethyltetrazole Intermediates in Sartan Syntheses Exist?
著者:: Iwona Dams, 等
出版事項: (2015-12-01)

Development and validation of stability-indicating RP-HPLC method for determination of Olmesartan medoxomile in pharmaceutical dosage form and identification, characterization of alkaline degradation impurity of Olmesartan medoxomile drug substance as well as drug product
著者:: Jain P.S., 等
出版事項: (2012-01-01)

ANTIHYPERTENSIVE EFFICACY OF OLMESARTAN MEDOXOMIL, A NEW ANGIOTENSIN II RECEPTOR ANTAGONIST, AS ASSESSED BY AMBULATORY BLOOD PRESSURE MEASUREMENTS
著者:: J. M. Neutel, 等
出版事項: (2011-04-01)

Efficacy and safety of olmesartan medoxomil‐amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single‐arm, multi‐center, real‐world study
著者:: Zhaoqiang Cui, 等
出版事項: (2024-01-01)

Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines
著者:: Omboni S, 等
出版事項: (2015-10-01)

High throughput microwell spectrophotometric assay for olmesartan medoxomil in tablets based on its charge-transfer reaction with DDQ
著者:: Darwish Ibrahim A., 等
出版事項: (2014-03-01)

EFFECTS OF OLMESARTAN ON LOCAL AND REGIONAL RIGIDITY OF ARTERIES IN ISCHEMIC HEART DISEASE
著者:: I. B. Matrosova, 等
出版事項: (2014-06-01)

Simultaneous quantitative analysis of olmesartan, amlodipine and hydrochlorothiazide in their combined dosage form utilizing classical and alternating least squares based chemometric methods
著者:: Darwish Hany W., 等
出版事項: (2016-03-01)

Enhancing Oral Absorption of an Ester Prodrug by Coating Drug Crystals with Binary Lipid Systems and Evaluating the Influence of Compositions
著者:: Xiaowei Dong, 等
出版事項: (2025-09-01)

Encapsulation of Risperidone by Methylated β-Cyclodextrins: Physicochemical and Molecular Modeling Studies
著者:: Laura Sbârcea, 等
出版事項: (2020-12-01)

Looking for an optimal antihypertensive combination. Focus on azilsartan medoxomil/chlorthalidone
著者:: M. D. Smirnova, 等
出版事項: (2025-01-01)

Enteropathy Associated with Olmesartan
著者:: Bruno Moreira da Silva, 等
出版事項: (2016-03-01)

MODERN OPPORTUNITIES FOR ANTIHYPERTENSION THERAPY: THE PLACE OF AZILSARTAN MEDOXOMIL
著者:: V. V. Skibitsky, 等
出版事項: (2017-12-01)

Olmesartan-Associated Enteropathy: An Unexpected Cause of Chronic Diarrhoea
著者:: Mónica Martins Teixeira, 等
出版事項: (2019-04-01)

Development and Evaluation of a Modified Fixed-Dose Combination Antihypertensive Tablet Containing S-Amlodipine Besylate: A Bioequivalence and Stability Study
著者:: Hyeon Woo Moon, 等
出版事項: (2025-09-01)

ANTIHYPERTENSIVE EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL AND RAMIPRIL IN ELDERLY PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION: THE ESPORT STUDY
著者:: E. Malacco, 等
出版事項: (2012-02-01)

Risperidone/Randomly Methylated β-Cyclodextrin Inclusion Complex—Compatibility Study with Pharmaceutical Excipients
著者:: Laura Sbârcea, 等
出版事項: (2021-03-01)

Host–Guest Complexation of Itraconazole with Cyclodextrins for Bioavailability Enhancement
著者:: Lenuţa-Maria Şuta, 等
出版事項: (2024-04-01)

Oxidative Thermolysis of Sulfobutyl-Ether-Beta-Cyclodextrin Sodium Salt: A Kinetic Study
著者:: Ionuț Ledeți, 等
出版事項: (2025-01-01)

Olmesartan-associated Enteropathy with Acute Kidney Injury
著者:: Moo Jin Kang, 等
出版事項: (2022-03-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND NEPHROPROTECTION: PLACE OF OLMESARTAN
著者:: V. V. Fomin
出版事項: (2013-08-01)

Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension
著者:: Attila Juhasz, 等
出版事項: (2018-02-01)

Up-to-Date Aspects of Antihypertensive Therapy from the Viewpoint of Cardioand Nephroprotective Action: Olmesartan
著者:: A. G. Evdokimova, 等
出版事項: (2020-05-01)

Atypical Rapid Onset of Olmesartan-Induced Enteropathy with Recurrence After Rechallenging
著者:: Lila Bekkai, 等
出版事項: (2025-07-01)

CLINICAL EFFECTS AND RENOPROTECTIVE FACILITIES OF OLMESARTAN AND LERKANIDIPINEAS MONOTHERAPY AND WHEN COMBINED APPLICATION IN PATIENTS WITH ARTERIAL HYPERTENSION
著者:: A G Evdokimova, 等
出版事項: (2016-03-01)

Olmesartan worsening known thrombocytopenia. A rare side effect of antihypertensive drugs
著者:: Elias A. Sanidas, 等
出版事項: (2017-01-01)

Efficacy and safety of azilsartan medoxomil in the treatment of hypertension: a systematic review and meta-analysis
著者:: Ling Zhu, 等
出版事項: (2024-07-01)

Clinical and Magnifying Narrow-Band Imaging Endoscopic Finding–Olmesartan-Associated Collagenous Gastroduodenitis
著者:: Pankaj Desai, 等
出版事項: (2020-06-01)

Novel Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Oral Delivery of Olmesartan Medoxomil: Design, Formulation, Pharmacokinetic and Bioavailability Evaluation
著者:: Ali Nasr, 等
出版事項: (2016-06-01)

Investigation of hydrolysis of olmesartan medoxomil in different pH buffers by simultaneously measuring olmesartan medoxomil and olmesartan.
著者:: Lauren Landry, 等
出版事項: (2025-01-01)

Severe Hepatitis Complicating Olmesartan Enteropathy: A Case Report
著者:: Ruyi Tan, 等
出版事項: (2024-04-01)